Pdt Partners, LLC Ardelyx, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $69,457 - $97,653	-13,754 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $72,208 - $97,378	13,754 New	13,754 $72,000
Q4 2017 Feb 14, 2018	SELL	$4.85 - $7.8 $467,176 - $751,335	-96,325 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.7 $419,013 - $549,052	96,325	96,325 $539,000

197

140M

1.25M

1.52M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $823M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.